Small-cap Healthcare company Nuwellis has logged a 3.8% change today on a trading volume of 2,286,751. The average volume for the stock is 63,675.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Based in Eden Prairie, United States the company has 70 full time employees and a market cap of $3,682,891.
The company is now trading -94.61% away from its average analyst target price of $216.67 per share. The 3 analysts following the stock have set target prices ranging from $75 to $300, and on average give Nuwellis a rating of buy.
Over the last year, NUWE shares have gone down by -91.8%, which represents a difference of -77.9% when compared to the S&P 500. The stock's 52 week high is $185 per share and its 52 week low is $9.55. Based on Nuwellis's average gross margin growth of 34.7% over the last four years, its core business remains strong and the stock price may recover in the long term.